Immunovant, Inc. IMVT United States — Effective tax rate
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateContinuingOperations.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s united states — effective tax rate.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Immunovant, Inc.'s united states — effective tax rate?
- Immunovant, Inc. (IMVT) reported united states — effective tax rate of 5.3% in Q1 2026.
- How has Immunovant, Inc.'s united states — effective tax rate changed year-over-year?
- Immunovant, Inc.'s united states — effective tax rate decreased by 0.0% year-over-year, from 5.3% to 5.3%.
- What is the long-term trend for Immunovant, Inc.'s united states — effective tax rate?
- Over 4 years (2022 to 2026), Immunovant, Inc.'s united states — effective tax rate has grown at a 0.0% compound annual growth rate (CAGR), from 21% to 21%.
- What does united states — effective tax rate mean?
- Calculated as the total income tax expense divided by the pre-tax income or loss for the United States segment. This ratio provides a standardized measure of the actual tax burden relative to domestic earnings, accounting for various tax credits and deductions. It is a critical metric for evaluating the company's tax management strategy.